Mazdutide 99% High Purity 5mg 10mg Weight Loss Peptides Cas 2259884-03-0
5 Inquiries
2259884-03-0
Pharmaceutical Grade
99%
ShangHai
HB
5mg 10mg /10vial,10vials/box
Yes
2026-12-31
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment
-
Average lead Time:
1 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
5-10
-
Year of Establishment:
2024
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025
United States
Mazdutide
30 MG Jul 15, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Tirzepatide Top quality peptide cosmetic peptide weight loss 99%purity
Pharmaceutical Grade / 99%
$40-50/UNIT FOB
-
-
-
-
Purity 99% MT 2 Raw Powder with Stable Quality for Scientific Studies
Pharmaceutical Grade / 99%
$50-60/MT FOB
-
-
-
-
Peptide Raw Material Custom Synthetic Peptides Bulk Peptide Powder
Pharmaceutical Grade / 99%
$6-7/G FOB
-
-
-
-
NAD Hight Purity CAS 53-84-9 Hot promotion beauty peptides delay cognitive decline anti-aging
Pharmaceutical Grade / 99%
$47-55/UNIT FOB
-
-
-
-
USP Grade Bacteriostatic Water BAC Water 3ml &10ml Vials, Sterile Solvent for Laboratory Research
Pharmaceutical Grade / 99%
$8-10/MT FOB
-
-
-
-
Selank 99% White powder High Quality Reduce stress Improve attention in stock
Pharmaceutical Grade / 99%
$38-45/UNIT FOB
-